High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β
- PMID: 31287614
- DOI: 10.1111/febs.14988
High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β
Abstract
Although the interaction of apoE isoforms with amyloid-β (Aβ) peptides plays a critical role in the progression of Alzheimer's disease, how they interact with each other remains poorly understood. Here, we investigate the molecular mechanism of apoE-Aβ interactions by comparing the effects of the different domains of apoE on Aβ. The kinetics of aggregation of Aβ1-42 are delayed dramatically in the presence of substoichiometric, nanomolar concentrations of N-terminal fragment (NTF), C-terminal fragment (CTF) and full-length apoE both in lipid-free and in lipidated forms. However, interactions between apoE and Aβ as measured by intermolecular Förster resonance energy transfer (FRET) analysis were found to be minimal at t = 0 but to increase in a time-dependent manner. Thus, apoE must interact with one or more 'intermediates' rather than the monomers of Aβ. Kinetics of FRET between full-length apoE4 labelled with EDANS at position 62 or 139 or 210 or 247 or 276, and tetramethylrhodamine-labelled Aβ (TMR-Aβ), further support an involvement of all the three domains of apoE in the interactions. However, the above-mentioned residues do not appear to form a single pocket in the 3-dimensional structure of apoE. A competitive binding assay examining the effects of unlabelled fragments or full-length apoE on the FRET between EDANS-apoE and TMR-Aβ show that binding affinity of the full-length apoE to Aβ is much higher than that of the fragments. Furthermore, apoE4 is found to interact more strongly than apoE3. We hypothesize that high affinity of the apoE-Aβ interaction is attained due to multivalent binding mediated by multiple interactions between oligomeric Aβ and full-length apoE.
Keywords: FRET; amyloid-β oligomers; apolipoprotein E; competitive binding; multivalent interactions.
© 2019 Federation of European Biochemical Societies.
Similar articles
-
Chemical cross-linking/mass spectrometry maps the amyloid β peptide binding region on both apolipoprotein E domains.ACS Chem Biol. 2015 Apr 17;10(4):1010-6. doi: 10.1021/cb500994j. Epub 2015 Jan 21. ACS Chem Biol. 2015. PMID: 25546376
-
The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.Biochemistry. 2014 Oct 14;53(40):6323-31. doi: 10.1021/bi5008172. Epub 2014 Sep 25. Biochemistry. 2014. PMID: 25207746 Free PMC article.
-
Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.Biochemistry. 1997 Aug 26;36(34):10571-80. doi: 10.1021/bi9626362. Biochemistry. 1997. PMID: 9265639
-
ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.J Mol Neurosci. 2004;23(3):235-46. doi: 10.1385/JMN:23:3:235. J Mol Neurosci. 2004. PMID: 15181252 Review.
-
The interaction of amyloid-beta with ApoE.Subcell Biochem. 2005;38:255-72. doi: 10.1007/0-387-23226-5_13. Subcell Biochem. 2005. PMID: 15709483 Review.
Cited by
-
Plasma IAPP-Autoantibody Levels in Alzheimer's Disease Patients Are Affected by APOE4 Status.Int J Mol Sci. 2023 Feb 14;24(4):3776. doi: 10.3390/ijms24043776. Int J Mol Sci. 2023. PMID: 36835187 Free PMC article.
-
Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.Neuron. 2021 Jan 20;109(2):205-221. doi: 10.1016/j.neuron.2020.10.008. Epub 2020 Nov 10. Neuron. 2021. PMID: 33176118 Free PMC article. Review.
-
An Alzheimer's Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease.J Alzheimers Dis. 2022;90(1):33-59. doi: 10.3233/JAD-220622. J Alzheimers Dis. 2022. PMID: 36155517 Free PMC article.
-
Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets.Front Aging Neurosci. 2023 Jun 2;15:1199434. doi: 10.3389/fnagi.2023.1199434. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37333457 Free PMC article. Review.
-
Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.J Alzheimers Dis. 2024;99(2):447-470. doi: 10.3233/JAD-240042. J Alzheimers Dis. 2024. PMID: 38669548 Free PMC article. Review.
References
-
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS & Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90, 1977-1981.
-
- Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM & Zlokovic BV (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118, 4002-4013.
-
- Jiang Q, Lee CYD, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL et al. (2008) ApoE promotes the proteolytic degradation of A beta. Neuron 58, 681-693.
-
- Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C et al. (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3, 89ra57.
-
- Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C & Holtzman DM (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci USA 110, E1807-E1816.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous